This is an external website. ITN is not responsible for any content on the third party website.
Proscia Gets FDA Clearance for Concentriq AP-Dx
Aug. 6, 2026 — Proscia has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Concentriq AP ...
Proscia Introduces Fifth Generation of Concentriq
June 17, 2026 — Proscia has introduced the Fifth Generation of its Concentriq1 platform, helping pathologists focus on ...